Catalyst Wire Dossier Catalyst Wire Dossier

PP110

· Peritech Pharma Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PP110, covering 2014-06-03 to 2014-06-03. Get the full timeline:

Most recent: Clinical Trial Update: A Prospective, Randomized, Three Arms, Open Label Study Comparing the Safety and Efficacy of Two Formulations of PP110 to the Active Comparator Preparation-H® Cream in the Treatment of Bleeding Hemorrhoids Grades 2-3 [Phase 2, Phase 3]

See pricing